Experience

International Alliance for Biological Standardization - IABS

• Switzerland
• Biotechnology Research
• 1 - 100 Employee

• Advisor to The Board at IABS

  • 1985 - Present

  In 1981, on the recommendation of Dr. Charles Mérieux, Dr. Gaudry was elected member of the IABS Board of Directors. In 1985, he became Secretary of IABS. After 35 years of services, he resigned from this position and was appointed Advisor to the Board. From 2008 to 2010, Dr. Gaudry served as President while continuing his function as Secretary of the Alliance. In 1981, on the recommendation of Dr. Charles Mérieux, Dr. Gaudry was elected member of the IABS Board of Directors. In 1985, he became Secretary of IABS. After 35 years of services, he resigned from this position and was appointed Advisor to the Board. From 2008 to 2010, Dr. Gaudry served as President while continuing his function as Secretary of the Alliance.



Institut Mérieux - Rhône Mérieux - Merial

• Development and Management of the Avian Product Line

  • 1968 - 2002

  In 1968, Dr. Gaudry started his career at Institut Mérieux, Lyon, France. He was instrumental in the development and the management of the avian product line at Institut Mérieux, then Rhône Mérieux, and finally Merial, both of which derived from Institut Mérieux. In 1968, Dr. Gaudry started his career at Institut Mérieux, Lyon, France. He was instrumental in the development and the management of the avian product line at Institut Mérieux, then Rhône Mérieux, and finally Merial, both of which derived from Institut Mérieux.



Merieux Institute, Inc. - Rhône-Mérieux, Inc.

• Development of a USDA-Approved Rabies Vaccine in the USA

  • 1980 - 1985

  Among Dr. Gaudry’s professional milestones was the set-up and initial development of the company’s U.S. veterinary subsidiary in Athens, Georgia in the 1980s. Since that time, the company has grown to become a major player in the veterinary field in the U.S. During his years at Rhône Mérieux, Dr. Gaudry succeeded in obtaining the first USDA-approved rabies vaccine for use by the subcutaneous route, a significant accomplishment in the field of veterinary medicine in the U.S. Among Dr. Gaudry’s professional milestones was the set-up and initial development of the company’s U.S. veterinary subsidiary in Athens, Georgia in the 1980s. Since that time, the company has grown to become a major player in the veterinary field in the U.S. During his years at Rhône Mérieux, Dr. Gaudry succeeded in obtaining the first USDA-approved rabies vaccine for use by the subcutaneous route, a significant accomplishment in the field of veterinary medicine in the U.S.